ANTI-CANCER DRUGS 期刊简介

ANTI-CANCER DRUGS
英文简介:

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

中文简介:(来自Google、百度翻译)

抗癌药物报告了与抗癌药物相关的临床和实验结果,并欢迎在抗癌药物设计,药物递送,药理学,激素和生物方式以及化学疗法评估方面做出贡献。国际推荐杂志致力于快速发表关于抗癌治疗剂的创新研究,抗癌药物旨在刺激和报告有毒和无毒抗癌剂的研究。因此,该杂志的范围将涵盖常规的细胞毒性化学疗法和激素或生物反应方式,例如白介素和免疫疗法。提交的文章经过编辑的初步审查。有些文章可能会退回给作者,而无需进一步考虑。那些被考虑出版的人将接受编辑的进一步评估和同行评审,以及那些被邀请从审稿人池中进行评估和同行评审。

期刊ISSN
0959-4973
影响指数
2.226
最新CiteScore值
4.40 查看CiteScore评价数据
最新自引率
1.50%
官方指定润色网址
https://www.deeredit.com/?type=ss1
投稿语言要求

Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted.

建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率

期刊官方网址

hot

https://www.peipusci.com/?type=9
杂志社征稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
偏重的研究方向(学科)
医学-药学
出版周期
Monthly
出版年份
1990
出版国家/地区
UNITED STATES
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
ANTI-CANCER DRUGS 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)4区 PHARMACOLOGY & PHARMACY(药学)4区
最新的影响因子
2.226
最新公布的期刊年发文量
年度总发文量 研究类文章占比
145 93.10%
总被引频次 88
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

ANTI-CANCER DRUGS 期刊CiteScore评价数据
最新CiteScore值
4.40
年文章数 145
SJR
0.651
SNIP
0.586
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Pharmacology (medical) #82/246
2 Medicine Pharmacology #126/297
3 Medicine Oncology #146/340
4 Medicine Cancer Research #122/207
CiteScore趋势图
CiteScore趋势图
ANTI-CANCER DRUGS 投稿经验(由下方点评分析获得,3人参与,3896人阅读)
投稿录用比例: 容易
审稿速度: 偏慢,4-8周
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司